Therapixel and Onsite Women’s Health Announce Partnership to Deploy MammoScreen® AI for Enhanced Breast Cancer Detection Across National Provider Network

PARIS and CHICAGO and NASHVILLE, Tenn., April 3, 2025 /PRNewswire/ — Therapixel, creators of MammoScreen®, a leading artificial intelligence (AI) solution for breast cancer screening, today announced a strategic partnership with Onsite Women’s Health, one of the nation’s largest…